Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Escudier, C Porta, M Schmidinger, F Algaba, JJ Patard, V Khoo, T Eisen, A Horwich
ANNALS OF ONCOLOGY | OXFORD UNIV PRESS | Published : 2014
MS reported honoraria for advisory boards and lectures from Roche, Bayer, Astellas, AVEO, Pfizer, GlaxoSmithKline and Novartis; she is conducting research sponsored by Pfizer and GlaxoSmithKline. JJP reported consultancy for Pfizer and GlaxoSmithKline; he reported being the principal investigator for a study funded by Pfizer. TE reported holding stock in AstraZeneca; he will take up a post as Vice president Clinical Discovery in AstraZeneca in September 2014; received honoraria for consultancy/lecture from Pfizer, GlaxoSmithKline, Novartis, Astellas/Aveo, Bayer Schering, Boehringer Ingelheim; and research or trial support from Pfizer, Bayer, AstraZeneca. BE reported honoraria received for consultancy/lecture from Bayer, Novartis, Pfizer, GlaxoSmithKline, Astellas. CP reported honoraria received for consultancy/lecture from Pfizer, GlaxoSmithKline, Novartis, Astellas/Aveo, Bayer Schering, Boehringer Ingelheim, Pierre Fabre; and research or trial support from Pfizer. AH, FA and VK have reported no potential conflicts of interest.